Extended Data Fig. 2: Serum biomarker fold change in relation to CRS occurrence. | Nature Cancer

Extended Data Fig. 2: Serum biomarker fold change in relation to CRS occurrence.

From: Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial

Extended Data Fig. 2: Serum biomarker fold change in relation to CRS occurrence.

Correlation between post-infusion (a) IL-6 and (b) CRP fold change and CRS occurrence in the I.P. and I.V. groups. In each boxplot, the central line represents the median, the box edges represent the interquartile range (IQR, 25th–75th percentile), and the whiskers extend to 1.5 × IQR. Statistical comparisons were performed using two‑sided Wilcoxon rank‑sum tests; no adjustment for multiple comparisons was applied. Abbreviations: CRS, cytokine release syndrome; I.P., intraperitoneal infusion; I.V., intravenous infusion; CRP, C-reactive protein; DL1, dose level 1; DL2, dose level 2; DL3, dose level 3; DL4, dose level 4.

Source data

Back to article page